Herpes Simplex Epidemiology Forecast

• The global burden of HSV-1 remains substantial, with an estimated ~3.8 billion individuals under 50 years of age infected worldwide, while approximately ~520 million people aged 15–49 years are living with HSV-2 infection, highlighting the widespread prevalence of HSV across both oral and genital disease settings. 
• The prevalence of HSV-2 infection increases with age and is disproportionately higher among women, primarily due to greater biological susceptibility and more efficient male-to-female sexual transmission, contributing to a higher disease burden in sexually active adult female populations. 
• HSV transmission frequently occurs through asymptomatic viral shedding, with studies demonstrating detectable genital HSV shedding even in individuals without recognized symptoms, underscoring the major role of subclinical infection in continued viral transmission and disease persistence. 

Herpes Simplex Epidemiology Forecast in the 7MM

• 2025 Incident Cases of Herpes Simplex: ~XX
• 2036 Projected Incident Cases of Herpes Simplex: ~XX 
• Herpes Simplex Growth Rate (2026–2036): XX% CAGR

DelveInsight's ‘Herpes Simplex– Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the herpes simplex, historical and forecasted epidemiology, in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Herpes Simplex Understanding and Diagnosis Algorithm

Herpes Simplex Overview and Diagnosis

Herpes Simplex Virus (HSV) is a lifelong viral infection caused by HSV-1 and HSV-2, primarily associated with oral and genital herpes, respectively. The virus spreads through direct oral, genital, or mucosal contact and may also be transmitted from mother to newborn during childbirth. Diagnosis is based on clinical evaluation supported by laboratory testing, with PCR serving as the most sensitive method for HSV detection, while serologic testing helps differentiate prior exposure to HSV-1 and HSV-2.

Further details are provided in the report.

Herpes Simplex Diagnosis

Diagnosis of HSV is based on clinical evaluation supported by laboratory testing. PCR is the most sensitive method for detecting HSV DNA from lesions, while viral culture may be used in certain cases. Serologic testing helps identify prior exposure and differentiate between HSV-1 and HSV-2, particularly in asymptomatic individuals.

Further details are provided in the report.

Herpes Simplex Epidemiology

Key Findings from Herpes Simplex Epidemiological Analysis and Forecast 

• According to the World Health Organization, HSV-1 infection is highly prevalent globally, with a large proportion of the population acquiring the infection during childhood, often through non-sexual contact. 
• Globally, HSV-2 remains a major cause of genital herpes, affecting hundreds of millions of individuals, with a higher burden observed in women compared to men. 
• HSV infections are lifelong and characterized by periods of latency and reactivation, contributing to recurrent disease and sustained transmission within populations. 
• A significant proportion of HSV infections remain asymptomatic or unrecognized, leading to underdiagnosis and continued spread of the virus. 
• The incidence of HSV-2 infection remains substantial worldwide, particularly among sexually active populations, with younger adults at higher risk of acquisition. 
• In the United States, epidemiological studies indicate a considerable burden of both HSV-1 and HSV-2 infections, with notable gender disparities and higher prevalence in females. 
• In the United States, epidemiological studies indicate a considerable burden of both HSV-1 and HSV-2 infections, with notable gender disparities and higher prevalence in females. 
• Across the EU4 and the UK, the total gender-specific cases of herpes simplex showed a higher prevalence among females, accounting for approximately 55% of cases, compared to around 45% among males.
• The prevalence of recurrent herpes simplex cases in Japan showed HSV-2 accounted for over ~70%, with HSV-1 following at ~30%.

Scope of the Herpes Simplex Market Report

• The Herpes Simplex Market report covers a segment of a descriptive overview of herpes simplex, explaining their causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression. 

Herpes Simplex Market Report Insights

Herpes Simplex Patient Population Forecast

Herpes Simplex Market Report Key Strengths

• Epidemiology‑based (Epi‑based) Bottom‑up Forecasting
• 11-year Forecast 
• Patient Burden Trends (by geography)

Explore comprehensive insights on the Herpes Simplex market insights, emerging therapies, epidemiology trends, and forecast opportunities through 2036 within the 7MM Counttries.

FAQs

• What are the disease risks, burdens, and unmet needs of herpes simplex? What will be the growth opportunities across the 7MM concerning the patient population with Herpes Simplex?
• What is the historical and forecasted herpes simplex patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy the Herpes Simplex Market Forecast Report

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders’ perspectives around the diagnostic challenges to overcome barriers in the future.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.